SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-042145
Filing Date
2021-06-21
Accepted
2021-06-21 17:19:13
Documents
2
Period of Report
2021-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7509
2 EX-24 DOCUMENT attachment1.htm EX-24 6139
  Complete submission text file 0001209191-21-042145.txt   15322
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Issuer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VYNE THERAPEUTICS 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address
Zeronda Tyler (Reporting) CIK: 0001867033 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38356 | Film No.: 211031948